Allergan swoops in as Takeda's third Shire bid falls short at $61B
admin 19th April 2018 Uncategorised 0Three of Takeda’s anticipated Shire buyout bids have already been rejected—and now, the Japanese drugmaker might just lose out to a competing bidder. Allergan, for instance, is already in talks for a buy.
More: Allergan swoops in as Takeda's third Shire bid falls short at B
Source: fierce